Neumora Therapeutics Inc (NMRA)
Stock chart
Loading...
•
Purchase
•
Sale
•
Planned purchase
•
Planned sale
Net purchase
Net sale
Earnings
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-02-20 | 2025-02-18 | PS Planned sale |
See Remarks Executive Director |
13,871
-0.2%
1.69USD 23,468 |
13,871 -0.2% | 1.69 | USD 23,468 | |
| 2025-02-20 | 2025-02-18 | PS Planned sale |
Chief Strategy Officer Officer |
8,565
-8.8%
1.68USD 14,347 |
8,565 -8.8% | 1.68 | USD 14,347 | |
| 2025-02-20 | 2025-02-18 | PS Planned sale |
President Officer |
8,048
-9.5%
1.67USD 13,477 |
8,048 -9.5% | 1.67 | USD 13,477 | |
| 2025-02-20 | 2025-02-18 | PS Planned sale |
See Remarks Officer |
1,978
-8.1%
1.69USD 3,351 |
1,978 -8.1% | 1.69 | USD 3,351 | |
| 2025-02-20 | 2025-02-18 | PS Planned sale |
Head of R&D Officer |
5,614
-1.8%
1.67USD 9,383 |
5,614 -1.8% | 1.67 | USD 9,383 | |
| 2024-10-18 | 2024-10-18 | PS Planned sale | Non-Executive Director |
14,049
-41.1%
17.03USD 239,319 |
14,049 -41.1% | 17.03 | USD 239,319 | |
| 2024-10-18 | 2024-10-17 | PS Planned sale | Non-Executive Director |
7,739
-27.8%
17.01USD 131,643 |
7,739 -27.8% | 17.01 | USD 131,643 | |
| 2024-10-11 | 2024-10-10 | PS Planned sale |
Head of R&D Officer |
8,260
-2.6%
15.09USD 124,603 |
8,260 -2.6% | 15.09 | USD 124,603 | |
| 2024-10-11 | 2024-10-09 | PS Planned sale |
Head of R&D Officer |
5,563
-1.7%
15.01USD 83,507 |
5,563 -1.7% | 15.01 | USD 83,507 | |
| 2024-09-19 | 2024-09-18 | PS Planned sale |
Head of R&D Officer |
10,676
-3.1%
12.09USD 129,091 |
10,676 -3.1% | 12.09 | USD 129,091 | |
| 2024-09-19 | 2024-09-17 | PS Planned sale |
Head of R&D Officer |
30,788
-8.3%
11.81USD 363,736 |
30,788 -8.3% | 11.81 | USD 363,736 | |
| 2024-09-16 | 2024-09-12 | PS Planned sale |
Head of R&D Officer |
32,948
-8.2%
11.43USD 376,665 |
32,948 -8.2% | 11.43 | USD 376,665 | |
| 2024-08-27 | 2024-08-27 | PS Planned sale |
Chief Financial Officer Officer |
15,693
-10.1%
11.39USD 178,806 |
15,693 -10.1% | 11.39 | USD 178,806 | |
| 2024-08-26 | 2024-08-26 | PS Planned sale |
Chief Financial Officer Officer |
31,642
-17.0%
11.78USD 372,588 |
31,642 -17.0% | 11.78 | USD 372,588 | |
| 2024-08-26 | 2024-08-23 | PS Planned sale |
Chief Financial Officer Officer |
24,169
-11.5%
11.59USD 280,005 |
24,169 -11.5% | 11.59 | USD 280,005 | |
| 2024-08-26 | 2024-08-22 | PS Planned sale |
Chief Financial Officer Officer |
28,496
-11.9%
11.63USD 331,468 |
28,496 -11.9% | 11.63 | USD 331,468 | |
| 2023-11-15 | 2023-11-14 | B Purchase |
ARCH Venture Partners XII, LLC Large shareholder |
3,357
+0.1%
11.98USD 40,217 |
3,357 +0.1% | 11.98 | USD 40,217 | |
| 2023-11-15 | 2023-11-14 | B Purchase | Non-Executive Director Large shareholder |
3,357
+0.1%
11.98USD 40,217 |
3,357 +0.1% | 11.98 | USD 40,217 | |
| 2023-11-15 | 2023-11-13 | B Purchase |
ARCH Venture Partners XII, LLC Large shareholder |
31,653
+0.8%
11.75USD 371,923 |
31,653 +0.8% | 11.75 | USD 371,923 | |
| 2023-11-15 | 2023-11-13 | B Purchase | Non-Executive Director Large shareholder |
31,653
+0.8%
11.75USD 371,923 |
31,653 +0.8% | 11.75 | USD 371,923 |